Preclinical models for development of immune–oncology therapies is a research paper published in Immuno Oncology Insights (2022). On theSindex it has a DataRank of 0.396. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.396
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NCI NIH HHS
Grant: P50 CA101942
NCI NIH HHS
Grant: K00 CA212227
National Institutes of Health
Grant: 2P50CA101942-11A1
DF/HCC Kidney Cancer SPORE
National Institutes of Health
Grant: 5K00CA212227-05
Imaging Cancer Angiogenesis with Acoustic Angiography Ultrasound
Fields of Study